Knee Bursitis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: K586DC310263EN
Market Monitor Global

Abstracts

Knee bursitis is inflammation of a small fluid-filled sac (bursa) situated near the knee joint. Bursae reduce friction and cushion pressure points between bones and the tendons, muscles, and skin near joints. Knee bursitis signs and symptoms vary, depending on which bursa is affected and what's causing the inflammation. Generally, the affected portion of knee might feel warm, tender, and swollen when pressure is applied.

This report contains market size and forecasts of Knee Bursitis Treatment in Global, including the following market information:

Global Knee Bursitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Knee Bursitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Knee Bursitis Treatment include Novartis, Pfizer, Merck, Amgen, Bayer, AVEO Pharmaceuticals, Bellicum Pharmaceuticals, MediaPharma and Merrimack Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Knee Bursitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Knee Bursitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Knee Bursitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Medication
• Surgery Therapy
• Others

Global Knee Bursitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Knee Bursitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Dermatology Centers
• Others

Global Knee Bursitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Knee Bursitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Knee Bursitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Knee Bursitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• Merck
• Amgen
• Bayer
• AVEO Pharmaceuticals
• Bellicum Pharmaceuticals
• MediaPharma
• Merrimack Pharmaceuticals
• Oncolys BioPharma
• United Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Knee Bursitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Knee Bursitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KNEE BURSITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Knee Bursitis Treatment Market Size: 2021 VS 2028
2.2 Global Knee Bursitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Knee Bursitis Treatment Players in Global Market
3.2 Top Global Knee Bursitis Treatment Companies Ranked by Revenue
3.3 Global Knee Bursitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Knee Bursitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Knee Bursitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Knee Bursitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Knee Bursitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Knee Bursitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Knee Bursitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medication
  4.1.3 Surgery Therapy
  4.1.4 Others
4.2 By Type - Global Knee Bursitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Knee Bursitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Knee Bursitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Knee Bursitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Dermatology Centers
  5.1.5 Others
5.2 By Application - Global Knee Bursitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Knee Bursitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Knee Bursitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Knee Bursitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Knee Bursitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Knee Bursitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Knee Bursitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Knee Bursitis Treatment Revenue, 2017-2028
  6.3.2 US Knee Bursitis Treatment Market Size, 2017-2028
  6.3.3 Canada Knee Bursitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Knee Bursitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Knee Bursitis Treatment Revenue, 2017-2028
  6.4.2 Germany Knee Bursitis Treatment Market Size, 2017-2028
  6.4.3 France Knee Bursitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Knee Bursitis Treatment Market Size, 2017-2028
  6.4.5 Italy Knee Bursitis Treatment Market Size, 2017-2028
  6.4.6 Russia Knee Bursitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Knee Bursitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Knee Bursitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Knee Bursitis Treatment Revenue, 2017-2028
  6.5.2 China Knee Bursitis Treatment Market Size, 2017-2028
  6.5.3 Japan Knee Bursitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Knee Bursitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Knee Bursitis Treatment Market Size, 2017-2028
  6.5.6 India Knee Bursitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Knee Bursitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Knee Bursitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Knee Bursitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Knee Bursitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Knee Bursitis Treatment Market Size, 2017-2028
  6.7.3 Israel Knee Bursitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Knee Bursitis Treatment Market Size, 2017-2028
  6.7.5 UAE Knee Bursitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Knee Bursitis Treatment Major Product Offerings
  7.1.4 Novartis Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Knee Bursitis Treatment Major Product Offerings
  7.2.4 Pfizer Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Knee Bursitis Treatment Major Product Offerings
  7.3.4 Merck Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Knee Bursitis Treatment Major Product Offerings
  7.4.4 Amgen Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Knee Bursitis Treatment Major Product Offerings
  7.5.4 Bayer Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 AVEO Pharmaceuticals
  7.6.1 AVEO Pharmaceuticals Corporate Summary
  7.6.2 AVEO Pharmaceuticals Business Overview
  7.6.3 AVEO Pharmaceuticals Knee Bursitis Treatment Major Product Offerings
  7.6.4 AVEO Pharmaceuticals Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.6.5 AVEO Pharmaceuticals Key News
7.7 Bellicum Pharmaceuticals
  7.7.1 Bellicum Pharmaceuticals Corporate Summary
  7.7.2 Bellicum Pharmaceuticals Business Overview
  7.7.3 Bellicum Pharmaceuticals Knee Bursitis Treatment Major Product Offerings
  7.7.4 Bellicum Pharmaceuticals Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bellicum Pharmaceuticals Key News
7.8 MediaPharma
  7.8.1 MediaPharma Corporate Summary
  7.8.2 MediaPharma Business Overview
  7.8.3 MediaPharma Knee Bursitis Treatment Major Product Offerings
  7.8.4 MediaPharma Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.8.5 MediaPharma Key News
7.9 Merrimack Pharmaceuticals
  7.9.1 Merrimack Pharmaceuticals Corporate Summary
  7.9.2 Merrimack Pharmaceuticals Business Overview
  7.9.3 Merrimack Pharmaceuticals Knee Bursitis Treatment Major Product Offerings
  7.9.4 Merrimack Pharmaceuticals Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Merrimack Pharmaceuticals Key News
7.10 Oncolys BioPharma
  7.10.1 Oncolys BioPharma Corporate Summary
  7.10.2 Oncolys BioPharma Business Overview
  7.10.3 Oncolys BioPharma Knee Bursitis Treatment Major Product Offerings
  7.10.4 Oncolys BioPharma Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.10.5 Oncolys BioPharma Key News
7.11 United Therapeutics
  7.11.1 United Therapeutics Corporate Summary
  7.11.2 United Therapeutics Business Overview
  7.11.3 United Therapeutics Knee Bursitis Treatment Major Product Offerings
  7.11.4 United Therapeutics Knee Bursitis Treatment Revenue in Global Market (2017-2022)
  7.11.5 United Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Knee Bursitis Treatment Market Opportunities & Trends in Global Market
Table 2. Knee Bursitis Treatment Market Drivers in Global Market
Table 3. Knee Bursitis Treatment Market Restraints in Global Market
Table 4. Key Players of Knee Bursitis Treatment in Global Market
Table 5. Top Knee Bursitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Knee Bursitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Knee Bursitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Knee Bursitis Treatment Product Type
Table 9. List of Global Tier 1 Knee Bursitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Knee Bursitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Knee Bursitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Knee Bursitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Knee Bursitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Knee Bursitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Knee Bursitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Knee Bursitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Knee Bursitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Knee Bursitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Knee Bursitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Knee Bursitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Knee Bursitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Knee Bursitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Knee Bursitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Knee Bursitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Knee Bursitis Treatment Product Offerings
Table 32. Novartis Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Knee Bursitis Treatment Product Offerings
Table 35. Pfizer Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Knee Bursitis Treatment Product Offerings
Table 38. Merck Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Knee Bursitis Treatment Product Offerings
Table 41. Amgen Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Knee Bursitis Treatment Product Offerings
Table 44. Bayer Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AVEO Pharmaceuticals Corporate Summary
Table 46. AVEO Pharmaceuticals Knee Bursitis Treatment Product Offerings
Table 47. AVEO Pharmaceuticals Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bellicum Pharmaceuticals Corporate Summary
Table 49. Bellicum Pharmaceuticals Knee Bursitis Treatment Product Offerings
Table 50. Bellicum Pharmaceuticals Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. MediaPharma Corporate Summary
Table 52. MediaPharma Knee Bursitis Treatment Product Offerings
Table 53. MediaPharma Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Merrimack Pharmaceuticals Corporate Summary
Table 55. Merrimack Pharmaceuticals Knee Bursitis Treatment Product Offerings
Table 56. Merrimack Pharmaceuticals Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Oncolys BioPharma Corporate Summary
Table 58. Oncolys BioPharma Knee Bursitis Treatment Product Offerings
Table 59. Oncolys BioPharma Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)
Table 60. United Therapeutics Corporate Summary
Table 61. United Therapeutics Knee Bursitis Treatment Product Offerings
Table 62. United Therapeutics Knee Bursitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Knee Bursitis Treatment Segment by Type in 2021
Figure 2. Knee Bursitis Treatment Segment by Application in 2021
Figure 3. Global Knee Bursitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Knee Bursitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Knee Bursitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Knee Bursitis Treatment Revenue in 2021
Figure 8. By Type - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Knee Bursitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Knee Bursitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AVEO Pharmaceuticals Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bellicum Pharmaceuticals Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MediaPharma Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merrimack Pharmaceuticals Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Oncolys BioPharma Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. United Therapeutics Knee Bursitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)